MTE #19: Optimizing Incretin Therapy in Women—Challenges and Opportunities (Ticketed)

Join us for an engaging session dedicated to exploring the emerging role of incretin therapy in women with liver disease. Led by specialists in hepatology and metabolic syndrome, this discussion synthesizes the latest evidence, clinical considerations, and gender-specific factors that influence the use of incretin-based treatments. Faculty present valuable insights into how these therapies can positively affect liver health, metabolic profiles, and overall outcomes among women. Speakers also examine the role of incretins across the reproductive lifespan—including during childbearing years, in polycystic ovary syndrome, and at menopause—highlighting their significance in women's unique physiological contexts. The multidisciplinary faculty aim to deepen understanding of personalized treatment strategies in this evolving field.